This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

May Guo
Chief Commercial Officer at Areterna
Speaker

Profile

May Guo is the Chief Commercial Officer for Synthgene, a company dedicated to develop and manufacture novel and high quality starting materials for mRNA, gRNA, siRNA and oligos. Prior to Synthgene, May worked for Arranta Bio, TriLink, Synthego, Agilent and Promega in various business development roles. She is passionate about new technologies and discoveries, particularly in the area of treating cancer and rare diseases. With 20 years of experience in the life science industry and extensive knowledge of mRNA, CRISPR, siRNA and LNP, May is in a good position to bring solutions to customers and connect people in the industry. May received her bachelor’s degree in chemistry from Peking University and MBA from Georgetown University.

Agenda Sessions

  • Discovering New Cap Analogs and Their Performances in Difference mRNA Constructs

    9:30am
  • Novel Cap Analogs and Modified NTPs to Enable Therapeutic mRNA Development

    12:20pm